Ask AI
BTKi in CLL 2025 Updates
BTK Inhibitors in CLL: Key Clinical Updates From ASCO & EHA 2025

Released: July 25, 2025

Expiration: January 24, 2026

Activity

Progress
1
Course Completed

In this episode, James Davis, PharmD, BCOP and Victoria Nachar, PharmD, BCOP summarize the latest key clinical updates on BTK inhibitors in CLL based on data recently presented at the annual ASCO and EHA meetings, including:

  • The randomized phase III FLAIR trial
  • The randomized phase III SEQUOIA trial
  • The randomized phase III BRUIN CLL-321 trial